Q69FE3 (Q69FE3_HUMAN) Homo sapiens (Human)
Interleukin-1 receptor-associated kinase 4 UniProtKBInterProInteractive Modelling
460 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: Q9NWZ3
Available Structures
82 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| The ternary Death Domain complex of MyD88, IRAK4, and IRAK2 |
Heteromer O43187; Q99836; Q9NWZ3; | 100 | ||||
| Crystal Structure of IRAK4 kinase in complex with the inhibitor CA-4948 | homo-4-mer | 100.0 | 4×FJ0; | |||
| Crystal structure of Compound 19 bound to IRAK4 | homo-4-mer | 100.0 | 4×QL7; 1×SO4; | |||
| CRYSTAL STRUCTURE OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 (IRAK4-WT) COMPLEX WITH A NICOTINAM… | homo-4-mer | 100.0 | 4×R7S; 10×SO4; | |||
| Crystal Structure of IRAK4 kinase in complex with a small molecule inhibitor | homo-4-mer | 100 | 4×FJ9; | |||
| Crystal structure of the unphosphorylated IRAK4 kinase domain Bound to a type I inhibitor | homo-2-mer | 99.64 | 2×DL1; | |||
| IRAK4 in complex with Ponatinib | homo-2-mer | 100.0 | 2×0LI; 2×SO4; 4×CO; | |||
| IRAK4 in complex with a type II inhibitor | homo-2-mer | 100.0 | 2×J8A; 2×SO4; 6×CO; | |||
| Crystal structure of the unphosphorylated IRAK4 kinase domain Bound to a type I inhibitor | homo-2-mer | 99.64 | 2×J87; | |||
| Crystal Structure of Asymmetric IRAK4 Dimer | homo-2-mer | 99.63 | 2×STU; 3×SO4; | |||
| Sulphur Anomalous Crystal Structure of Asymmetric IRAK4 Dimer | homo-2-mer | 99.63 | 2×STU; 3×SO4; | |||
| IRAK4 in complex with compound 20 | monomer | 100.0 | 1×WFQ; | |||
| Crystal structure of IRAK4 in complex with compound 6 | monomer | 100.0 | 1×A1AFH; | |||
| Crystal structure of IRAK4 in complex with compound 4 | monomer | 100 | 1×A1AFO; | |||
| Structure of the IRAK4 kinase domain with compound 41 | monomer | 100.0 | 1×SO4; 1×LSV; | |||
| Irak4-inhibitor co-structure | monomer | 100.0 | 1×4S2; | |||
| Crystal structure of IRAK4 in complex with compound 14 | monomer | 100.0 | 1×8CD; | |||
| Crystal structure of IRAK4 kinase domain apo form | monomer | 100.0 | ||||
| Crystal structure of IRAK4 kinase domain with compound 9 | monomer | 100 | 1×YJU; 1×CL; 2×GOL; | |||
| Crystal structure of human Interleukin-1 receptor associated Kinase 4 (IRAK 4, CID 100300) in compl… | monomer | 100.0 | 1×JX4; | |||
| Crystal structure of IRAK4 kinase domain with inhibitor | monomer | 100.0 | 1×XPY; | |||
| Irak4-inhibitor co-structure | monomer | 100.0 | 1×4S3; | |||
| Irak4 kinase - compound 1 co-structure | monomer | 100.0 | 1×76Q; | |||
| Irak4-inhibitor co-structure | monomer | 100.0 | 1×4GD; | |||
| Irak4 kinase - compound 1 co-structure | monomer | 100.0 | 1×76P; | |||
| Structure of the IRAK4 kinase domain with compound 5 | monomer | 100.0 | 1×LTY; | |||
| IRAK4 IN COMPLEX WITH inhibitor | monomer | 100.0 | 5×ND2; | |||
| Crystal structure of the inactive unphosphorylated IRAK4 kinase domain bound to AMP-PNP | monomer | 99.65 | 1×ANP; 2×SO4; 1×MG; | |||
| Irak4-inhibitor co-structure | monomer | 100.0 | 1×6YE; | |||
| Discovery of IRAK4 Inhibitor 41 | monomer | 100.0 | 1×R73; | |||
| Irak4-inhibitor co-structure | monomer | 100.0 | 1×42P; | |||
| Crystal structure of IRAK4 kinase domain with compound 4 | monomer | 100.0 | 1×Y9T; 2×GOL; 1×SO4; | |||
| IRAK4 in complex with compound 8 | monomer | 100.0 | 1×X1T; | |||
| Structure of the IRAK4 kinase domain with compound 17 | monomer | 100.0 | 1×CA; 1×LRS; | |||
| IRAK4 bound to benzoxazole compound | monomer | 100.0 | 1×KFD; | |||
| IRAK4 in complex with compound | monomer | 100.0 | 1×VEU; 2×EDO; | |||
| IRAK4 in complex with compound 24 | monomer | 100.0 | 1×VDC; | |||
| IRAK4 in complex with inhibitor | monomer | 100.0 | 1×EXF; | |||
| Crystal structure of IRAK4 kinase domain complexed with staurosporine | monomer | 100.0 | 1×STU; | |||
| Crystal structure of IRAK4 kinase domain with compound 8 | monomer | 100.0 | 1×YK0; 1×EDO; | |||
| Crystal structure of IRAK4 in complex with compound 9 | monomer | 100.0 | 1×8BV; | |||
| Irak4-inhibitor co-structure | monomer | 100.0 | 1×4GF; | |||
| Crystal structure of IRAK4 in complex with compound 23 | monomer | 100.0 | 1×LS7; 1×SO4; 1×GOL; | |||
| IRAK4 in complex with inhibitor | monomer | 100.0 | 1×N9Z; | |||
| Crystal structure of IRAK-4 | monomer | 100 | 1×SO4; 1×T12; | |||
| IRAK4 in complex with Compound 1 | monomer | 100.0 | 1×6QX; | |||
| IRAK4 in complex with inhibitor | monomer | 100.0 | 1×B4U; | |||
| Crystal structure of IRAK-4 | monomer | 100.0 | 1×STU; | |||
| Discovery of IRAK4 Inhibitor 40 | monomer | 98.96 | 1×R6I; | |||
| Discovery of IRAK4 Inhibitor 38 | monomer | 98.94 | 1×O06; | |||
| IRAK4 in complex with Compound 21 | monomer | 100.0 | 2×SO4; 1×6QY; | |||
| IRAK4 in complex with AZ3862 | monomer | 100.0 | 2×SO4; 1×6R0; | |||
| CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 9) | monomer | 100.0 | 1×9YS; | |||
| Crystal structure of IRAK4 kinase domain complexed with AMPPNP | monomer | 100.0 | 1×ANP; | |||
| IRAK4 in complex with AZ3864 | monomer | 100.0 | 1×6QZ; | |||
| IRAK4 IN COMPLEX WITH inhibitor | monomer | 100.0 | 1×NBW; | |||
| Discovery of IRAK4 Inhibitor 16 | monomer | 98.93 | 1×O0H; 1×GOL; | |||
| IRAK4 IN COMPLEX WITH inhibitor | monomer | 100.0 | 1×CJN; | |||
| IRAK4 IN COMPLEX WITH inhibitor | monomer | 100.0 | 1×SO4; 1×CJT; | |||
| Irak4-inhibitor co-structure | monomer | 100.0 | 1×4S1; | |||
| Apo IRAK4 Kinase Domain | monomer | 100.0 | ||||
| IRAK4 in complex with inhibitor | monomer | 100.0 | 1×NBK; | |||
| IRAK4 IN COMPLEX WITH COMPOUND #3 | monomer | 100.0 | 1×SO9; 1×BME; | |||
| Discovery of IRAK4 Inhibitor 23 | monomer | 98.94 | 1×O6X; | |||
| IRAK4 IN COMPLEX WITH inhibitor | monomer | 100.0 | 1×SO4; 1×CJQ; | |||
| CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 4) | monomer | 100.0 | 1×9YY; | |||
| IRAK4 in complex with inhibitor | monomer | 100.0 | 1×B6I; | |||
| The Crystal Structure of IRAK4 from Biortus | monomer | 99.66 | 1×8CG; 3×EDO; 1×SO4; | |||
| Crystal structure of IRAK4 in complex with compound 30 | monomer | 100.0 | 1×8CG; | |||
| IRAK4 in complex with inhibitor | monomer | 100.0 | 1×B8I; | |||
| Discovery of IRAK4 Inhibitors BAY1834845 and BAY1830839 | monomer | 98.9 | 1×R6R; | |||
| IRAK4 IN COMPLEX WITH inhibitor | monomer | 100.0 | 1×CKN; | |||
| Crystal Structure of IRAK-4 | monomer | 100.0 | 1×T20; | |||
| IRAK4 in complex with inhibitor | monomer | 100.0 | 1×B7R; | |||
| IRAK4 IN COMPLEX WITH inhibitor | monomer | 100.0 | 1×SO4; 1×K1H; | |||
| IRAK4 IN COMPLEX WITH inhibitor | monomer | 100.0 | 1×NB5; | |||
| Crystal structure of IRAK4 in complex with compound 12 | monomer | 100.0 | 1×8C1; | |||
| IRAK4 IN COMPLEX WITH inhibitor | monomer | 100.0 | 1×K1E; | |||
| Crystal structure of IRAK4 in complex with compound 11 | monomer | 100.0 | 1×8BY; | |||
| IRAK4 in complex with Compound 28 | monomer | 100.0 | 1×6R1; | |||
| IRAK4 in complex with compound 23 | monomer | 100.0 | 1×VE9; | |||
| Irak4-inhibitor co-structure | monomer | 100.0 | ||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8dks.1.A | monomer | 0.84 | 1×SO9; | 100.00 | ||
| 2a9i.1.A | monomer | 0.82 | 86.73 | |||